About Dr. David Battleman
Dr. Battleman is a seasoned healthcare executive with over 20+ years of experience, spanning academia, industry, and management consulting. Prior to establishing his advisory firm, TrueNorth Lifesciences, Dr. Battleman served as a senior principal in the R&D and commercial strategy practice within IMS Health Holdings, Inc. (now IQVIA; NYSE: IQV), a Fortune 500 company providing data and consulting services to the global pharmaceutical industry. Prior to joining IMS Health, he was a management consultant at Bain & Company and executive director for Pfizer Pharmaceuticals. Within academia, he was an assistant professor of Public Health & Medicine at Cornell University’s Weill Cornell Medical College. While at Cornell, Dr. Battleman’s research focused primarily on health economics and technology assessment, and he has published both original research and expert reviews in these areas.
TrueNorth Lifesciences takes a unique multi-dimensional approach toward healthcare & life science investing, evaluating not only the scientific, clinical, and regulatory risks (i.e., likelihood of technical success) but also carefully evaluating commercial risk and opportunity (i.e., likelihood and magnitude of commercial success) across global markets. For highly innovative early-stage healthcare & life science companies, TrueNorth provides strategic consulting & financial advisory services to accelerate growth and optimize drug, device medical diagnostic as well as healthcare services development and commercialization. We differentiate based on our unique ability to advise and align R&D/commercialization strategies with financing strategies. And as a Managing Director at Pickwick Capital Partners, Dr. Battleman can assemble experienced financing teams to execute on private placements, strategic partnerships and/or M&A in both the public & private markets
Additionally, TrueNorth Lifesciences works with a distinctive network of elite family offices, hedge funds, and HNW / UHNW individuals providing buy-side advisory services on healthcare and biotech-related investments.
Dr. Battleman holds an M.D. from Weill Cornell Medical College, an M.B.A. from the University of Pennsylvania’s Wharton School of Business, and an M.Sc. from the Harvard School of Public Health. Dr. Battleman also holds his Series 63 and 82 licenses and, as mentioned, is a FINRA-registered representative with Pickwick Capital Partners.
